Immuneering Corporation

NasdaqGM:IMRX Stock Report

Market Cap: US$72.7m

Immuneering Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:IMRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Apr 24SellUS$1,160,181Cormorant Asset Management, LPCompany400,000US$3.07
22 Mar 24BuyUS$7,385Thomas SchallIndividual2,900US$2.55
22 Mar 24BuyUS$4,009Mallory MoralesIndividual1,500US$2.72
22 Mar 24BuyUS$10,015Harold BrakewoodIndividual3,900US$2.57
22 Mar 24BuyUS$63,713Peter FeinbergIndividual25,000US$2.55
20 Mar 24BuyUS$20,020Brett HallIndividual7,000US$2.86
20 Mar 24BuyUS$10,993Leah NeufeldIndividual3,818US$2.88
19 Mar 24BuyUS$55,326Benjamin ZeskindIndividual20,000US$2.77
19 Mar 24BuyUS$183,058Peter FeinbergIndividual75,000US$3.05
18 Mar 24BuyUS$123,436Ann BermanIndividual57,965US$2.13
15 Mar 24SellUS$2,391,765Cormorant Asset Management, LPCompany843,836US$4.25
14 Mar 24SellUS$357,238Cormorant Asset Management, LPCompany65,255US$5.97

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMRX?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,354,60614%
Individual Insiders8,660,40827.9%
General Public18,035,43458.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.1%.

Top Shareholders

Top 25 shareholders own 41.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.2%
Benjamin Zeskind
3,176,779US$7.4m0%no data
8.92%
Seth Merrin
2,770,386US$6.5m0%no data
3.7%
Robert Carpenter
1,148,839US$2.7m0%no data
3.53%
Peter Feinberg
1,096,064US$2.6m0%no data
3.45%
The Vanguard Group, Inc.
1,070,322US$2.5m0%no data
2.61%
T. Rowe Price Group, Inc.
810,127US$1.9m-5.73%no data
1.45%
Morgan Stanley, Investment Banking and Brokerage Investments
449,311US$1.1m880%no data
1.11%
Brett Hall
345,896US$809.4k0%no data
1.03%
BlackRock, Inc.
318,419US$745.1k-40.3%no data
0.79%
Millennium Management LLC
246,270US$576.3k-74.2%no data
0.68%
Geode Capital Management, LLC
209,641US$490.6k-5.48%no data
0.66%
Southport Management, L.L.C.
205,000US$479.7k28%1.73%
0.61%
Prosight Management, LP
190,000US$444.6k-65.5%0.11%
0.49%
TD Asset Management, Inc.
150,876US$353.1k0%no data
0.27%
Manulife Asset Management
82,638US$193.4k0%no data
0.22%
State Street Global Advisors, Inc.
69,235US$162.0k0%no data
0.22%
Ann Berman
67,465US$157.9k0%no data
0.21%
Corient Private Wealth LLC
63,740US$149.2k47%no data
0.19%
Exchange Traded Concepts, LLC
58,349US$136.5k-22.1%no data
0.17%
HighTower Advisors, LLC
53,360US$124.9k21.4%no data
0.17%
Tidemark, LLC
51,850US$121.3k0%0.05%
0.13%
Two Sigma Investments, LP
40,431US$94.6k-80.8%no data
0.13%
Northern Trust Global Investments
39,729US$93.0k-75%no data
0.1%
UBS Asset Management AG
31,545US$73.8k347%no data
0.1%
Bank of America Corporation, Asset Management Arm
31,087US$72.7k-3.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 07:32
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Immuneering Corporation is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yevgeniya LivshitsChardan Capital Markets, LLC
Michael SchmidtGuggenheim Securities, LLC
Michael YeeJefferies LLC